Background: The benefits of dual antiplatelet therapy with aspirin and a P2Y12 receptor antagonist (DAPT) in Acute coronary Syndrome and those undergoing percutaneous coronary interventions has been clearly established…
wisely CHA2DS2-VASc embolism risk scale aids in making this decision. But, is dual antiplatelet therapy, acetylsalicylic acid plus clopidogrel, a correct option in embolism prevention in atrial fibrillation ... primary…
reviewed and the possible role of pharmacogenetics and pharmacometabonomics in the personalization of antiplatelet therapy with ticagrelor was discussed. Result: This review identified that pharmacometabonomic…
evidence on the efficacy and safety of dual antiplatelet therapy for secondary stroke prevention have been realized in the recent years. An updated meta analysis was done to determine
Background: Brain hemorrhage is a serious complication of antiplatelet therapy, particularly dual antiplatelet therapy (DAPT), in patients with coronary artery disease (CAD) who undergo percutaneous coronary…
Background: Cilostazol added to Dual Antiplatelet Therapy (DAT: aspirin, clopidogrel) reduces revascularization without increased bleeding in patients after Drug-Eluting Stent (DES) implantation. However, doubts remain…
Abstract New evidence on the efficacy and safety of dual antiplatelet therapy for secondary stroke prevention has been realized in the recent years. An updated meta-analysis was done ... included in the meta-analysis by…
Antiplatelet therapy plays an integral role in the treatment of ischemic heart disease, the leading cause of death in most Western Countries. Previously, the classes of antiplatelet drugs that proved ... ticagrelor)…
determine the optimal duration of dual antiplatelet therapy and the risk–benefit ratio for long-term dual antiplatelet therapy after drug-eluting stents, several clinical studies have been performed
mortality and recurrence rate. However, the use of Drug–Eluting Stent (DES) and Dual Antiplatelet Therapy (DAPT) have shown to give auspicious reduction in the complication rate. The mechanisms contributing…
Dual antiplatelet therapy forms currently the basis in acute coronary syndrome pharmacological treatment. However, there is a wide variability in antiplatelet response to clopidogrel, which may lead to antiplatelet…
studies have revealed that platelets have a direct influence on arrhythmic events. However, current antiplatelet therapy have failed to prevent sudden cardiac death in primary prevention trials, although a protective
complications in patients with multiple stents implanted. In this clinical setting, optimal upfront dual antiplatelet therapy (DAPT) duration still remains controversial. Herein, we wish to report a case of life
investigated the real dual antiplatelet therapy (DAPT) duration after the drug-eluting stent (DES) treatment in China. 9,919 consecutive patients with DES implantation were enrolled. The follow-up DAPT
this work is to assess the risk factors for restenosis on the antiplatelet therapy background after PCI. Materials: A questionnaire was tested on patients after PCI who received double ... triple antiplatelet therapy. A…
angina (UA) and non-ST elevation myocardial infarction (NSTEMI) involve the use of dual antiplatelet therapy (DAPT: aspirin + ADP P2Y12 inhibitor), whereas the use of triple antiplatelet therapy (TAPT: aspirin ... been…
Perioperative management of patients with an indication for dual antiplatelet therapy (DAPT) and, in particular, patients during the first weeks after coronary stent implantation remains a challenging task for both
have had percutaneous coronary intervention for acute coronary syndromes or stable angina dual antiplatelet therapy is required. If there is a history of atrial fibrillation, thrombosis or presence ... mechanical heart…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.